Eden BioSolutions Plc logo

Eden BioSolutions Plc(LSE) EDEN

Market Cap£19.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1996)-100%
5 Year-65%
1 Year+5%
1 Month+24%
£0.03
-1.11%
-0.00Today
Eden BioSolutions Plc last closing stock price
MetricPriceDate
Last closeGBX 2.672026-10-15
Eden BioSolutions Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+11.25%GBX 2.402026-10-08
1 month+24.19%GBX 2.152026-09-15
3 month-7.93%GBX 2.902026-07-17
Year to date+0.75%GBX 2.652025-12-31
1 year+4.71%GBX 2.552025-10-15
3 year-46.06%GBX 4.952023-10-16
5 year-64.98%GBX 7.632021-10-15
Since inception-99.61%GBX 6.301996-09-04

Eden BioSolutions Plc Financials at a Glance

Market Cap

£19.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£7.55M

Net Income (TTM)

-£3.87M

EPS (TTM)

£0.00

P/E Ratio

0.00

Dividend

£0.00

Beta (Volatility)

0.02 (Low)

Price

£0.03

Volume

153,022

Open

£0.02

Previous Close

£0.03

Daily Range

£0.02 - £0.03

52-Week Range

£0.02 - £0.05

Estimated Earnings Date

Dec 16, 2026

EDEN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eden BioSolutions Plc

Eden Biosolutions PLC specializes in sustainable solutions for crop protection, animal health, and consumer products across the UK and Europe. The company offers a diverse range of plant protection products and animal health solutions, focusing on environmentally friendly practices.

Products and Services
  • Plant protection products for foliar disease control and soil pests
  • Animal health products including shampoos and parasite treatments
  • Human health products such as wound care and food flavorings
Growth Outlook
  • Market demand for sustainable agricultural solutions is increasing
  • Expansion into new European markets is underway
  • Investment in R&D aims to enhance product offerings and efficacy
Financial Highlights
  • Recent quarterly revenue of 1,198,535 GBP shows potential for growth
  • Trailing twelve months (TTM) revenue of 6,000,000 GBP indicates stability
  • Current ratio of 1.95 suggests strong short-term financial health
Eden Biosolutions PLC is positioned in the agricultural inputs industry, focusing on innovative and sustainable solutions. The company's diverse product range addresses critical needs in crop protection and animal health, aligning with global trends towards sustainability. Recent financial data indicates a revenue of 1,198,535 GBP for the latest quarter, reflecting a positive trajectory. The TTM revenue of 6,000,000 GBP further underscores the company's potential for stability and growth. With a current ratio of 1.95, Eden Biosolutions demonstrates a solid short-term financial position, which is crucial for navigating the competitive landscape of agricultural inputs. The ongoing investment in research and development is expected to enhance product offerings, catering to the growing demand for sustainable solutions in agriculture and health sectors.
AI Generated • Oct 8, 2026

Industry

Chemicals

Sector

Materials

CEO

Sean Michael Smith

Website

edenresearch.co.uk

Headquarters

Abingdon, OX OX14 4RQ, GB

EDEN Financials

Key Financial Metrics (TTM)

Gross Margin

29.29%

Operating Margin

-58.94%

Net Income Margin

-50.43%

Return on Equity

-16.16%

Return on Capital

-17.48%

Return on Assets

-11.98%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£19.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

803.36M

Volume

153.02K

Avg. Volume

597.00K

Financials (TTM)

Gross Profit

£3.32M

Operating Income

-£4.51M

EBITDA

-£3.12M

Operating Cash Flow

-£2.19M

Capital Expenditure

-£649.27K

Free Cash Flow

-£2.84M

Cash & ST Invst.

£1.85M

Total Debt

£571.86K

Eden BioSolutions Plc Performance Analysis

Eden BioSolutions Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 1,827,17148.7%
20232023-12-31GBP 3,192,02774.7%
20242024-12-31GBP 4,302,60334.8%
20262026-03-31GBP 3,881,812-9.8%
Eden BioSolutions Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-3179.4%
Q22024-06-30-8.0%
Q42024-12-3128.1%
Q22025-06-30-50.4%
Eden BioSolutions Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP -0.01-19.2%
20232023-12-31GBP -0.02161.0%
20242024-12-31GBP -0.00-76.6%
20262026-03-31GBP -0.000.0%
Eden BioSolutions Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-3191.6%
Q22024-06-30-30.8%
Q42024-12-31-11.8%
Q22025-06-30-36.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

£1.20M

+4.9%

Gross Profit

£113.13K

+70.6%

Gross Margin

9.44%

N/A

Market Cap

£19.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£855.76K

N/A

Employees

23

N/A

Net Income

-£1.36M

+76.9%

EBITDA

-£1.16M

-38.3%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

£1.85M

+274.6%

Total Debt

£571.86K

+99.5%

Accounts Receivable

£2.73M

+302.3%

Inventory

£652.69K

+0.2%

Long Term Debt

£445.12K

+201.2%

Short Term Debt

£126.74K

-8.7%

Return on Assets

-11.98%

N/A

Return on Invested Capital

-17.70%

N/A

Free Cash Flow

-£1.01M

+30.3%

Operating Cash Flow

-£508.02K

+50.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EML.LEmmerson PLC
£0.01+3.70%
KDNC.LCadence Minerals Plc
£0.05+2.15%
ITX.LItaconix plc
£1.84+0.27%
KRPZ.LKropz plc
£0.00-19.24%

Trending Stocks

Symbol / CompanyPricePrice Chg
CCCCCC Intelligent Solutions
$7.62-0.33%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$101.30-8.36%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$46.04+8.28%
INTCIntel
$93.22-4.99%

Questions About EDEN

What is the current price of Eden BioSolutions Plc?

Eden BioSolutions Plc is trading at £0.03 per share.

What is the 52-week range for Eden BioSolutions Plc?

Over the past 52 weeks, Eden BioSolutions Plc has traded between £0.02 and £0.05.

How much debt does Eden BioSolutions Plc have?

As of the most recent reporting period, Eden BioSolutions Plc reported total debt of £671.91K.

How much cash does Eden BioSolutions Plc have on hand?

Eden BioSolutions Plc reported £1.52M in cash and cash equivalents in its most recent financial results.

What is Eden BioSolutions Plc’s dividend yield?

Eden BioSolutions Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services